Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hip Resurfacing Technology Aids S&N Stock Gain In Q1 - Index Up 1.1%

This article was originally published in The Gray Sheet

Executive Summary

Investor enthusiasm for hip resurfacing's market potential was among factors contributing to Smith & Nephew's 21.3% stock price gain in the first quarter

You may also be interested in...



Smith & Nephew Unveils CEO Succession Plan, Cost-Cutting Measures

Incoming Smith & Nephew CEO David Illingworth's top priority will be a cost-cutting strategy to improve profit margins by an average of 1% annually through 2010

Smith & Nephew Unveils CEO Succession Plan, Cost-Cutting Measures

Incoming Smith & Nephew CEO David Illingworth's top priority will be a cost-cutting strategy to improve profit margins by an average of 1% annually through 2010

Smith & Nephew Plus: $889 Million Buy Expands European Reconstruction Biz

Smith & Nephew will double its share of the European orthopedic reconstructive implant market with its $889 million acquisition of Plus Orthopedic Holding

Related Content

UsernamePublicRestriction

Register

LL1132440

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel